AHG
Income statement / Annual
Last year (2026), Akso Health Group's total revenue was $13.83 M,
a decrease of 6.40% from the previous year.
In 2026, Akso Health Group's net income was -$18.67 M.
See Akso Health Group,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2026
|
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
03/31/2026 |
03/31/2025 |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
| Operating Revenue |
$13.83 M |
$14.78 M |
$2.41 M |
$13.18 M |
$6.00 M |
$1.75 M |
$6.91 M |
$3.70 M |
$107.26 M |
$22.92 M |
| Cost of Revenue |
$13.84 M
|
$15.06 M
|
$2.29 M
|
$11.91 M
|
$5.39 M
|
$544.57 K
|
$0.00
|
$0.00
|
$8.50 M
|
$5.15 M
|
| Gross Profit |
-$11.32 K
|
-$281.53 K
|
$122.13 K
|
$1.27 M
|
$605.13 K
|
$1.21 M
|
$6.91 M
|
$3.70 M
|
$98.76 M
|
$17.77 M
|
| Gross Profit Ratio |
-0
|
-0.02
|
0.05
|
0.1
|
0.1
|
0.69
|
1
|
1
|
0.92
|
0.78
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$421.19 K
|
$441.41 K
|
$1.03 M
|
$0.00
|
$8.50 M
|
$5.15 M
|
| General & Administrative Expenses |
$3.99 M
|
$3.64 M
|
$8.59 M
|
$15.53 M
|
$2.67 M
|
$2.03 M
|
$20.84 M
|
$9.72 M
|
$7.64 M
|
$2.65 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$168.42 K
|
$6.66 K
|
$391.63 K
|
$55.47 K
|
$1.46 M
|
$1.17 M
|
$15.24 M
|
$5.21 M
|
| Selling, General & Administrative Expenses |
$3.99 M
|
$3.64 M
|
$8.76 M
|
$15.54 M
|
$3.06 M
|
$2.09 M
|
$22.30 M
|
$10.88 M
|
$22.89 M
|
$7.86 M
|
| Other Expenses |
$0.00
|
$162.38 M
|
$0.00
|
$0.00
|
$382.95 K
|
$25.83 M
|
$31.69 M
|
$0.00
|
-$8.50 M
|
-$5.15 M
|
| Operating Expenses |
$3.99 M
|
$166.02 M
|
$8.76 M
|
$15.54 M
|
$3.87 M
|
$28.36 M
|
$55.02 M
|
$10.88 M
|
$22.89 M
|
$7.86 M
|
| Cost And Expenses |
$17.83 M
|
$181.08 M
|
$11.05 M
|
$27.45 M
|
$9.26 M
|
$28.90 M
|
$55.02 M
|
$10.88 M
|
$31.38 M
|
$13.01 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$590.12 K
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$804.14 K
|
$2.15 M
|
$2.50 M
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$2.37 M
|
$2.15 M
|
$0.00
|
$18.39 K
|
$18.39 K
|
$15.16 K
|
$120.52 K
|
$17.23 K
|
$174.38 K
|
$92.22 K
|
| EBITDA |
-$1.63 M |
-$1.77 M |
-$8.64 M |
-$14.27 M |
-$3.19 M |
-$28.90 M |
-$44.25 M |
-$6.79 M |
$76.71 M |
$10.01 M |
| EBITDA Ratio |
-0.12
|
-0.12
|
-3.58
|
-1.08
|
-0.53
|
-16.47
|
-6.4
|
-1.84
|
0.72
|
0.44
|
| Operating Income Ratio |
-0.29
|
-11.25
|
-3.58
|
-1.08
|
-0.54
|
-15.47
|
-6.96
|
-1.95
|
0.71
|
0.43
|
| Total Other Income/Expenses Net |
-$16.70 M
|
$34.07 K
|
-$453.75 K
|
$1.20 M
|
-$747.82 K
|
$23.34 M
|
$1.23 M
|
$381.15 K
|
$660.88 K
|
$179.53 K
|
| Income Before Tax |
-$20.70 M
|
-$166.27 M
|
-$9.09 M
|
-$13.07 M
|
-$4.01 M
|
-$3.81 M
|
-$46.87 M
|
-$6.81 M
|
$76.54 M
|
$10.09 M
|
| Income Before Tax Ratio |
-1.5
|
-11.25
|
-3.77
|
-0.99
|
-0.67
|
-2.17
|
-6.78
|
-1.84
|
0.71
|
0.44
|
| Income Tax Expense |
-$1.99 M
|
-$30.80 M
|
$24.99 K
|
$17.55 K
|
$92.82 K
|
$482.98 K
|
$489.96 K
|
$807.71 K
|
$11.03 M
|
$1.52 M
|
| Net Income |
-$18.67 M
|
-$134.98 M
|
-$9.46 M
|
-$1.36 M
|
-$16.85 M
|
-$34.83 M
|
-$71.20 M
|
$5.53 M
|
$65.48 M
|
$8.57 M
|
| Net Income Ratio |
-1.35
|
-9.13
|
-3.92
|
-0.1
|
-2.81
|
-19.85
|
-10.3
|
1.5
|
0.61
|
0.37
|
| EPS |
-0.03 |
-0.48 |
-0.45 |
-0.06 |
-2.55 |
-0.26 |
-13.14 |
0.93 |
12.36 |
1.62 |
| EPS Diluted |
-0.03 |
-0.48 |
-0.39 |
-0.06 |
-2.55 |
-0.27 |
-13.14 |
0.93 |
12.36 |
1.62 |
| Weighted Average Shares Out |
$722.71 M
|
$285.10 M
|
$20.81 M
|
$7.62 M
|
$6.62 M
|
$5.43 M
|
$5.42 M
|
$5.88 M
|
$5.30 M
|
$5.32 M
|
| Weighted Average Shares Out Diluted |
$722.71 M
|
$285.10 M
|
$23.83 M
|
$7.62 M
|
$6.62 M
|
$5.43 M
|
$5.42 M
|
$5.88 M
|
$5.30 M
|
$5.32 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
